🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Want to work for a fast-paced, mission-driven organization? Look no further! ICER is looking to expand our team: grnh.se/0514dc8d3us

New from the "Insights from ICER" series in #HAScholar: Sarah K. Emond and Catherine Koola Fischer explore how ICER works to ensure that patient community voices and values are central in drug value assessments. Read the full article here: bit.ly/4jLLw2W

Catch up on the latest in HTA! The newest edition of the HTAi Review is out now—featuring news and updates from the global HTA community! ➡️ htai.org/htai-review-ap…

Institute for Clinical and Economic Review to Assess Treatments for Obesity Management: tinyurl.com/452a2w9t

Process update! When submitting a paper to an ISPOR journal, you’ll have some new questions to answer. We now collect data on #PatientEngagement and offer #OpenScience badges! #ValueInHealth #ValueInHealthRegionalIssues

📰 The latest issue of the HTAi Review is here! From recent opportunities and developments to global HTA news, this edition is packed with updates you won’t want to miss. Read now: htai.org/htai-review-ma…

SUSTAIN-HTA Consortium met in Budapest for the 3rd General Assembly & 1st joint Advisory Group meeting. The two-day event hosted senior experts and leaders of HTA bodies, ISPOR, HTAi & other strategic HTA initiatives all met in Budapest to discuss collaboration in HTA.

💡 Just Released: HTAi Global Policy Forum White Paper, "Building Momentum and Moving Forward Together: The Path Ahead for the Digital Transformation of HTA." Explore the role of Generative AI in improving the efficiency and accuracy of HTA activities ➡️ htai.org/wp-content/upl…

The ISPOR Women in Health Economics and Outcomes Research Initiative has published a new report in this month’s issue of #ValueInHealth. Read the article here: ow.ly/U7h150VVgi2 Read the press release here: ow.ly/A48x50VVgi3 #WomenInHEOR

ICER #WeeklyView: A new ICER assessment, Launch Price and Access Report protocol, & states grapple with obesity Rx coverage conta.cc/4kaZjRo

Stay connected! The latest HTAi Review is out now, with updates from our global community, new opportunities, and highlights to keep you in the know. Read it now ➡️ htai.org/htai-review-ma… World Health Organization (WHO) NCD Alliance IECS Argentina

Institute for Clinical and Economic Review Releases Draft Evidence Report on Treatments for Spinal Muscular Atrophy: tinyurl.com/yneckwdh

ICER #WeeklyView: SMA Draft Report, MS Evidence Report, & Colorado PDAB on Enbrel conta.cc/4mAsaQy

Catch up on recent webinars now available for on-demand viewing! Topics covered include #causalAI in #HEOR, the impact of delayed #patientaccess to #cancer treatment, and the challenges in treating #DuchenneMuscularDystrophy. More here>> ow.ly/QmsA50VZrl3

Early HTA is ".. a health technology assessment conducted to inform decisions about subsequent development, research and/or investment by explicitly evaluating the potential value of a conceptual or actual health technology” HTAi cambridge.org/core/journals/…

Learn how real-world evidence is revealing trends & critical gaps in patients’ diagnosis, prescribing, & adherence in a webinar on June 10. Brought to you by Truveta. Details>> ow.ly/yRyp50VZqSU #RWE #realworldevidence #cardiovasculardisease #diabetes #ADHD #HIV

🚀 Dive into AI with us! Join “Artificial Intelligence for All” on Mon, 9 June 2025 | 16:00–17:00 (BKK time) 🎙️ With: Dr. Adeel Munawar (SIITTU) Mr. Tariq Shah (#Connexus & #ArchilabsAI, USA) 📍 HITAP Room 1 or 💻 Zoom 🔗 Register: us06web.zoom.us/webinar/regist…

Join us at 1PM EDT tomorrow, June 10, for a webinar that will explore the results of studies on #cardiovasculardisease, #diabetes, ADHD and #HIV that used Truveta’s new accelerated research program. Brought to you by ISPOR Corporate Partner, Truveta. ow.ly/FEC350W06jw

This Friday -- at 12 PM ET join us for the virtual public meeting on the comparative clinical effectiveness and value of tolebrutinib (made by Sanofi) for the treatment of secondary progressive multiple sclerosis. Register here: shorturl.at/j33Ny #heor #hta

Have you read the new issue of the HTAi Review? Check it out for details on the HTAi 2025 Annual Meeting, updates from the HTAi Interest Groups, and the the latest news from the global HTA community! ➡️ htai.org/htai-review-ju… #HTAi2025 #HTA